Related Experiment Video
Updated: May 7, 2026

10:37
Development of Recombinant Proteins to Treat Chronic Pain
Published on: April 11, 2018
9.5K
Inflammatory pain resolution by mouse serum-derived small extracellular vesicles
Zhucheng Lin1, Xuan Luo1, Jason R Wickman1
1Department of Pharmacology & Physiology, Drexel University College of Medicine, 245 North 15th Street, Philadelphia, PA 19102, USA.
Biorxiv : the Preprint Server for Biology
|February 26, 2024
Summary
Small extracellular vesicles (sEVs) show potential for pain management. Prophylactic sEV injections in mice delayed pain and accelerated recovery by modulating immune responses.
Area of Science:
- Neuroscience
- Immunology
- Biotechnology
Background:
- Chronic pain presents a significant public health challenge with limited treatment options.
- Small extracellular vesicles (sEVs), including exosomes, are investigated for their potential to deliver therapeutic biomolecules.
- The immunomodulatory and pain-resolving capabilities of sEVs require further elucidation.
Conclusions:
- Mouse serum-derived sEVs can modulate pain through opioid signaling and immunomodulation.
- Prophylactic sEV administration offers therapeutic potential for chronic and inflammatory pain.
- sEVs represent a promising strategy for pain management by influencing immune cell responses.

